HEXAGON AB B FRIA
HEXAGON AB B FRIA
Share · SE0015961909 · ZIVO (XSTO)
Overview Financial Indicators
No Price
09.09.2025 19:13
1 day
-
1 week
-
1 month
-
3 months
-
6 months
-
Year to date
-
1 year
-
2 years
-
3 years
-
4 years
-
5 years
-
10 years
-
20 years
-
Max
-
Analyst Grade Summary
gauge-img
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
0
1
0
0
Current Prices from HEXAGON AB B FRIA
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
ZIVO
USD
09.09.2025 19:13
13,50 USD
-1,35 USD
-9,09 %
Share Float & Liquidity
Free Float 47,87 EUR
Shares Float 1,83 M EUR
Shares Outstanding 3,82 M EUR
Invested Funds

The following funds have invested in HEXAGON AB B FRIA:

Fund
iShares OMX Stockholm Capped UCITS ETF
Vol. in million
278.838,92
Percentage (%)
4,09 %
Fund
iShares STOXX Europe 600 Technology UCITS ETF (DE)
Vol. in million
11.839,61
Percentage (%)
3,66 %
Fund
iShares MSCI Europe Information Technology Sector UCITS ETF EUR (Acc)
Vol. in million
253,55
Percentage (%)
3,48 %
Fund
iShares Smart City Infrastructure UCITS ETF USD (Acc)
Vol. in million
2.538,18
Percentage (%)
0,83 %
Fund
iShares Smart City Infrastructure UCITS ETF USD (Dist)
Vol. in million
489,46
Percentage (%)
0,83 %
Company Profile for HEXAGON AB B FRIA Share
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

Company Data

Name HEXAGON AB B FRIA
Company ZIVO Bioscience, Inc.
Symbol ZIVO
Website https://www.zivobioscience.com
Primary Exchange XSTO NASDAQ STOCKHOLM AB
ISIN SE0015961909
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO John Bernard Payne
Market Capitalization 69 Mio
Country United States of America
Currency SEK
Employees 0,0 T
Address 21 East Long Lake Road, 48304 Bloomfield Hills
IPO Date 2003-12-15

ID Changes

Date From To
10.11.2014 HEPI ZIVO

Ticker Symbols

Name Symbol
Frankfurt HXG.F
NASDAQ ZIVO
More Shares
Investors who hold HEXAGON AB B FRIA also have the following shares in their portfolio:
AMUNDI INDEX J.P. MORGAN EMU GOVIES IG - IE (D)
AMUNDI INDEX J.P. MORGAN EMU GOVIES IG - IE (D) ETF
CARL ZEISS MEDITEC AG
CARL ZEISS MEDITEC AG Share
DANAHER CORP
DANAHER CORP Share
ECKERT & ZIEGLER AG
ECKERT & ZIEGLER AG Share
HOME DEPOT INC
HOME DEPOT INC Share
INTUIT INC
INTUIT INC Share
LAM RESEARCH CORP
LAM RESEARCH CORP Share
LVMH MOET HENNESSY LOUIS VUITTON SE
LVMH MOET HENNESSY LOUIS VUITTON SE Share
Optoelectronics Co.,Ltd.
Optoelectronics Co.,Ltd. Share
ORACLE CORP
ORACLE CORP Share
PAYPAL INC
PAYPAL INC Share
RESMED INC
RESMED INC Share
STARBUCKS CORP
STARBUCKS CORP Share
TOLL BROTHERS
TOLL BROTHERS Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025